website templates

PKA SOFTTOUCH 

Painless, Accurate, Rapid & Safe

CHANGING THE WORLD ONE PAINLESS INJECTION AT A TIME

Mobirise

INDUSTRY REPORTS

Milestones Achieved

Safety and Efficacy Evaluation of the Micro-Needle Insulin Injection of Healthy Dogs, University of Guelph.
Clinical Study to evaluate the performance of the Micro-Needle injection device in dogs using insulin and Atropine, University of Guelph.

Proof of Concept Human Clinical Trial Data in Type-1 Diabetics (St. Joseph's Hospital, Diabetes Research Unit, Toronto).

The device was cleared by the US-FDA for large scale human clinical trials related to insulin. Canadian, U.S., European Union (26 Countries), South African, New Zealand, Japanese, and Australian patents have been issued. (Total of 32 Countries)

Brazil, India and Argentina Patents are pending.
An advanced version (Generation V) of the device is completed.

PKA SoftTouch has developed and perfected technology to stabilize insulin at room temperatures. This is exclusive and will be patent protected.

Mobirise

FOLLOW US!

© Copyright 2019 Mobirise - All Rights Reserved